Optomed PLC (OPTOMED)

Helsinki
12.60
+0.55(+4.56%)
  • Volume:
    62,240
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    12.30 - 12.90
  • Type:Equity
  • Market:Finland
  • ISIN:FI4000410881
  • S/N:14003144

OPTOMED Overview

Prev. Close
12.05
Day's Range
12.3-12.9
Revenue
15.33M
Open
12.3
52 wk Range
4.92-19.15
EPS
-0.18
Volume
62,240
Market Cap
163.15M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
43,650
P/E Ratio
-
Beta
-
1-Year Change
121.1%
Shares Outstanding
13,539,177
Next Earnings Date
30 Nov 2021
What is your sentiment on Optomed PLC?
or
Vote to see community's results!

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyBuyBuy
Technical IndicatorsBuyStrong BuyStrong BuyNeutralStrong Buy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy

Optomed PLC Company Profile

Optomed PLC Company Profile

Employees
0
Market
Finland

Optomed Oyj, a medical technology company, provides handheld fundus cameras and eye-screening devices in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. It offers handheld fundus camera products, which are used in ophthalmology, pediatric care, endocrinology, neurology, and primary care. Its product portfolio consists of Optomed Smartscope Pro, Optomed Aurora, and Optomed Aava, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal; and desktops cameras, such as Optomed Polaris tabletop fundus cameras and Optomed Halo portable retinal cameras. The company also provides Optomed Avenue, a Software-as-a-Service (SaaS) platform that offers access to artificial intelligence services, screening process management tools, and remote image analyses; Avenue Eye Screen, a workflow management system for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Telemedicine, a remote analysis solution for faster access to medical consultation; Avenue Viewer, a patient data management solution for viewing, reporting, and archiving fundus images; and Avenue Sync, a software solution. In addition, it offers process management software for various cancer screenings; radiology information system, a software system for healthcare imaging units for managing medical images and associated data; and solution for digital pathology. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company’s customers include hospitals, eye clinics, and optician chains and stores. The company was founded in 2004 and is headquartered in Oulu, Finland.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.